Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin

BackgroundStatins have several effects beyond their well-known antihyperlipidemic activity, which include immunomodulatory, antioxidative and anticoagulant effects. In this study, we have tested the possible antimicrobial activity of statins against a range of standard bacterial strains and bacterial clinical isolates.MethodsMinimum inhibitory concentrations (MIC) values were evaluated and compared among three members of the statins drug (atorvastatin, simvastatin, and rosuvastatin).ResultsIt was revealed that statins are able to induce variable degrees of antibacterial activity with atorvastatin, and simvastatin being the more potent than rosuvastatin. Methicillin-sensitive staphylococcus aureus (MSSA), methicillin-resistant staphylococcus aureus (MRSA), vancomycin-susceptible enterococci (VSE), vancomycin-resistant enterococcus (VRE), acinetobacter baumannii, staphylococcus epidermidis, and enterobacter aerogenes, were more sensitive to both atorvastatin, and simvastatin compared to rosuvastatin. On the other hand, escherichia coli, proteus mirabilis, and enterobacter cloacae were more sensitive to atorvastatin compared to both simvastatin and rosuvastatin. Furthermore, most clinical isolates were less sensitive to statins compared to their corresponding standard strains.ConclusionOur findings might raise the possibility of a potentially important antibacterial class effect for statins especially, atorvastatin and simvastatin.

[1]  K. Liao,et al.  Fluvastatin ameliorates endotoxin induced multiple organ failure in conscious rats. , 2007, Resuscitation.

[2]  M. Ferraro.  Performance standards for antimicrobial susceptibility testing , 2001 .

[3]  F. Gudiol,et al.  Statins for community-acquired pneumonia: current state of the science , 2010, European Journal of Clinical Microbiology & Infectious Diseases.

[4]  Raimund Erbel,et al.  Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. , 2006, JAMA.

[5]  P. Głuszko,et al.  [Statins--are they potentially useful in rheumatology?]. , 2007, Polskie Archiwum Medycyny Wewnetrznej.

[6]  Ping Li,et al.  Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis , 2006, The Lancet.

[7]  D. Wallwiener,et al.  Class-specific pro-apoptotic effect of statins on human vascular endothelial cells , 2004, Zeitschrift für Kardiologie.

[8]  Henrik C Schønheyder,et al.  Statin use and mortality within 180 days after bacteremia: A population-based cohort study* , 2006, Critical care medicine.

[9]  V. Novack,et al.  Prior Statin Therapy Is Associated With a Decreased Rate of Severe Sepsis , 2004, Circulation.

[10]  C. Weber,et al.  Statin Treatment After Onset of Sepsis in a Murine Model Improves Survival , 2005, Circulation.

[11]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[12]  T. Kodama,et al.  Influence of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on ubiquinone levels in rat skeletal muscle and heart: relationship to cytotoxicity and inhibitory activity for cholesterol synthesis in human skeletal muscle cells. , 2006, Journal of atherosclerosis and thrombosis.

[13]  C. Weber,et al.  HMG-CoA Reductase Inhibitor Simvastatin Profoundly Improves Survival in a Murine Model of Sepsis , 2004, Circulation.

[14]  J. Lindh,et al.  What is a relevant statin concentration in cell experiments claiming pleiotropic effects? , 2011, British journal of clinical pharmacology.

[15]  P. Libby,et al.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. , 2008, The New England journal of medicine.

[16]  H. Shimano,et al.  Distinct effects of pravastatin, atorvastatin, and simvastatin on insulin secretion from a beta-cell line, MIN6 cells. , 2006, Journal of atherosclerosis and thrombosis.

[17]  R. Rosenson,et al.  Statins and sepsis: multiple modifications at multiple levels. , 2007, The Lancet. Infectious diseases.

[18]  J. Brandão-Neto,et al.  Effects of simvastatin in abdominal sepsis in rats. , 2006, Acta cirurgica brasileira.

[19]  Anton Pohanka,et al.  Studies on the Antibacterial Effects of Statins - In Vitro and In Vivo , 2011, PloS one.

[20]  Mark Jones,et al.  Statin therapy is associated with fewer deaths in patients with bacteraemia , 2005, Intensive Care Medicine.

[21]  J. Farmer.  Pleiotropic effects of statins , 2000, Current atherosclerosis reports.

[22]  K. Mann,et al.  Statins and Blood Coagulation , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[23]  R. McPherson,et al.  Comparative effects of rosuvastatin and atorvastatin across their dose ranges in patients with hypercholesterolemia and without active arterial disease. , 2003, The American journal of cardiology.

[24]  A. Liappis,et al.  The effect of statins on mortality in patients with bacteremia. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  V. Rodwell,et al.  The 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductases , 2004, Genome Biology.

[26]  Yiannis S. Chatzizisis,et al.  Risk Factors and Drug Interactions Predisposing to Statin-Induced Myopathy Implications for Risk Assessment , Prevention and Treatment , 2012 .

[27]  Nina Singh,et al.  Antimicrobial and immunomodulatory attributes of statins: relevance in solid-organ transplant recipients. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  Alex J Sutton,et al.  Statins for the prevention and treatment of infections: a systematic review and meta-analysis. , 2009, Archives of internal medicine.

[29]  C. Furberg.  Natural statins and stroke risk. , 1999, Circulation.

[30]  J. Cohen,et al.  Unexpected antimicrobial effect of statins. , 2007, The Journal of antimicrobial chemotherapy.

[31]  A. Welsh,et al.  Antimicrobial action of atorvastatin and rosuvastatin. , 2009, Pathology.

[32]  V. Novack,et al.  The effects of statin therapy on inflammatory cytokines in patients with bacterial infections: a randomized double-blind placebo controlled clinical trial , 2009, Intensive Care Medicine.

[33]  H. Redmond,et al.  Statin (cerivastatin) protects mice against sepsis-related death via reduced proinflammatory cytokines and enhanced bacterial clearance. , 2008, Surgical infections.

[34]  H. Milionis,et al.  An Overview of the Extra-Lipid Effects of Rosuvastatin , 2008, Journal of cardiovascular pharmacology and therapeutics.

[35]  C. Mawrin,et al.  Cytotoxic effect of different statins and thiazolidinediones on malignant glioma cells , 2011, Cancer Chemotherapy and Pharmacology.

[36]  R. Gregg,et al.  Differential effects of pravastatin, simvastatin, and atorvastatin on Ca2+ release and vascular reactivity. , 1999, Journal of cardiovascular pharmacology.